Purple Biotech Regains Nasdaq Compliance

Purple Biotech (PPBT) has released an update.

Purple Biotech Ltd. has successfully met the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as confirmed by the Nasdaq Listing Qualifications Department. The company’s American Depositary Shares maintained a closing bid price of at least $1.00 for over 10 consecutive business days, securing its compliance and closing the matter.

For further insights into PPBT stock, check out TipRanks’ Stock Analysis page.